Alexander Snyder. For Profit or For Health? It is Time to Reckon With the Current Pharmaceutical Landscape Through a Systematic Analysis of Monoclonal Anitbodies. tlp [Internet]. 2021 Aug. 26 [cited 2024 Apr. 20];21(2). Available from: http://tlp.law.pitt.edu/ojs/tlp/article/view/251